Retatrutide is an investigational triple receptor agonist (GLP-1, GIP, glucagon) that remains unlicensed in the UK, with no MHRA approval, no NHS availability, and no BNF listing as of 20242025
Months 3-6: Approaching the Maintenance Phase What the trials documented: By around month four (week 17), the REDEFINE protocol reached the 2.4 mg maintenance dose, and weight loss continued to accrue beyond that point through the 68-week primary endpoint (Aronne et al., 2025)
The core lies in the Proxylane anti-aging mechanism : it mimics xylose to stimulate glycosaminoglycans (GAGs) synthesis, thereby Repairing the basement membrane and reinforcing the DEJ junction
Addressing Common Concerns It's natural to have questions and concerns when considering vitamin injections
Both Epithalon (with H) and Epitalon (without H) appear in the published research literature and across research-supply listings
Our vitamin injections provide targeted support, helping your body receive exactly what it needs to feel energized, balanced, and supported